Registered entities
SYNAPTOGENIX, INC.
Reg. No. 46-1585656United States
NEUROTROPE, INC.
Reg. No. 1513856United States
Innovation
11 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace steady. Cited 828 times.
| Year | Filings |
|---|---|
| 2021 | 1 |
| 2022 | 6 |
| 2023 | 7 |
| 2024 | 8 |
| 2025 | 3 |
Investor mix
12 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 8% |
| Private equity | 4 | 33% |
| Other / undisclosed | 7 | 58% |